ANGELA SPEARS: Open Payments
NPI 1053956094 · VESTAVIA HILLS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 35 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $179 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $276 |
| ABBVIE INC. | 5 | $188 |
| Journey Medical Corporation | 2 | $147 |
| Kerecis Limited | 3 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Galderma Laboratories, L.P. | 4 | $69 |
| Amgen Inc. | 3 | $67 |
| Lilly USA, LLC | 2 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $39 |
| Organogenesis Inc. | 1 | $31 |
Products named: OPZELURA, SKYRIZI, Kerecis SurgiClose, NEMLUVIO, OTEZLA, COSENTYX, EBGLYSS, AFFINITY.
Industry payments across AL — which companies pay providers there.
